Doris Hansen, MD

Articles by Doris Hansen, MD

Dr. Hansen on the Utilization of BCMA-Directed Therapy in Multiple Myeloma

ByDoris Hansen, MD

October 21st 2021

Doris Hansen, MD, discusses the utilization of BCMA-directed therapy in multiple myeloma.

Doris Hansen, MD, of Moffitt Cancer Center

Dr. Hansen on the Promise of ALLO-715 in Relapsed/Refractory Multiple Myeloma

ByDoris Hansen, MD

October 12th 2021

Doris Hansen, MD, discusses the promise of ALLO-715 in relapsed/refractory multiple myeloma. Scroll to 0:07 in the video for Dr. Hansen's topline points on the agent.

Dr. Hansen on the PFS Benefit With Ide-Cel in Relapsed/Refractory MM

ByDoris Hansen, MD

October 7th 2021

Doris Hansen, MD, discusses the progression-free survival benefit yielded by idecabtagene vicleucel on the phase 2 KarMMa trial in patients with pretreated relapsed/refractory multiple myeloma.